Kudo Biotechnology, a mRNA contract development and manufacturing organization (CDMO), is delighted to be attending the upcoming BIO Asia-Taiwan 2023 International Conference & Exhibition on-site, held from July 26-30 in Taipei City, at the Taipei Nangang Exhibition Center (TaiNEX). This event will be attended by more than 300 companies and 500 delegates from around the world.

Organized by global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO), this year’s Conference theme is Embracing Asian Dynamics, showcasing the remarkable opportunities that Asia affords, as well as its vibrant biomedical ecosystems that are interconnected with the rest of the world. Such a theme resonates deeply with us, since Kudo Biotechnology is a global organization with a presence in the US, China and Singapore, and serving customers worldwide with our deep expertise in global regulatory requirements.

Kudo Biotechnology is also glad to be sponsoring Session 12, on the topic of New Modality Development, on Friday July 28th, Day 3 of the Conference. Join us as we explore the latest and most promising new therapeutic modalities that are transforming healthcare today. As a CDMO and solutions provider for pDNA, mRNA and LNP needs, we are proud to be contributing to the rapidly growing field of RNA-based vaccines and therapies. This will be one of the topics fielded at this Session, discussing latest trends, developments and future possibilities in new modalities in therapeutics.

Join us on-site or virtually at this annual event, and find out more about our solutions and how we enable our customers to achieve the best quality, performance and speed for their pDNA, mRNA and LNP products.

To find out more, contact us at info@kudobio.com

See you there at BIO Asia-Taiwan next week!